Adriano Venditti

13.9k total citations
259 papers, 5.6k citations indexed

About

Adriano Venditti is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Adriano Venditti has authored 259 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Hematology, 85 papers in Molecular Biology and 67 papers in Genetics. Recurrent topics in Adriano Venditti's work include Acute Myeloid Leukemia Research (167 papers), Acute Lymphoblastic Leukemia research (62 papers) and Hematopoietic Stem Cell Transplantation (40 papers). Adriano Venditti is often cited by papers focused on Acute Myeloid Leukemia Research (167 papers), Acute Lymphoblastic Leukemia research (62 papers) and Hematopoietic Stem Cell Transplantation (40 papers). Adriano Venditti collaborates with scholars based in Italy, United States and United Kingdom. Adriano Venditti's co-authors include Francesco Buccisano, Sergio Amadori, Giovanni Del Poeta, Luca Maurillo, Maria Ilaria Del Principe, Roberto Stasi, Maria Christina Cox, Anna Tamburini, Mario Masi and Francesco Lo‐Coco and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Adriano Venditti

242 papers receiving 5.4k citations

Peers

Countries citing papers authored by Adriano Venditti

Since Specialization

Citations

This map shows the geographic impact of Adriano Venditti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriano Venditti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriano Venditti more than expected).

Fields of papers citing papers by Adriano Venditti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriano Venditti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriano Venditti. The network helps show where Adriano Venditti may publish in the future.

Co-authorship network of co-authors of Adriano Venditti

This figure shows the co-authorship network connecting the top 25 collaborators of Adriano Venditti. A scholar is included among the top collaborators of Adriano Venditti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriano Venditti. Adriano Venditti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of CPX-351 in the Acute Myeloid Leukemia Treatment Landscape: Mechanism of Action, Efficacy, and Safety 2025 ·Drugs ·Livio Pagano, Romano Danesi, E. Benedetti, (unknown), Luigina Romani, Adriano Venditti	1
2	Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response 2025 ·Journal of Clinical Medicine ·(unknown), Giovangiacinto Paterno, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Buccisano, Luca Maurillo, Raffaele Palmieri, Carmelo Gurnari, Adriano Venditti, Maria Ilaria Del Principe	1
3	The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 2024 ·Thrombosis Research ·Giovangiacinto Paterno, Raffaele Palmieri, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carmelo Gurnari, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe	4
4	A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice 2024 ·SHILAP Revista de lepidopterología ·(unknown), Alfonso Piciocchi, (unknown), Stefano Soddu, Francesco Buccisano, Cristina Mecucci, Giovanni Martinelli, Antonio Curti, Roberto Cairoli, Paola Fazi, Marco Vignetti, Maria Teresa Voso, Adriano Venditti, Anna Candoni	0
5	Fatal acute graft-versus-host disease in Sézary Syndrome treated with Mogamulizumab and hematopoietic cell transplantation 2024 ·Current Research in Translational Medicine ·(unknown), (unknown), (unknown), (unknown), (unknown), Lucia Anemona, (unknown), Gottardo De Angelis, (unknown), F Bonanni, (unknown), (unknown), (unknown), (unknown), Antonio Bruno, Maria Cantonetti, Adriano Venditti, Raffaella Cerretti	1
6	CT Images in Follicular Lymphoma: Changes after Treatment Are Predictive of Cardiac Toxicity in Patients Treated with Anthracycline-Based or R-B Regimens 2024 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Francesco Garaci, Adriano Venditti, Massimiliano Postorino, Marcello Chiocchi	1
7	Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia 2024 ·Cancers ·Alessandro Nanni Costa, Carmelo Gurnari, Emilia Scalzulli, Laura Cicconi, (unknown), Ida Carmosino, Raffaella Cerretti, (unknown), Saveria Capria, Clara Minotti, Anna Paola Iori, (unknown), Adriano Venditti, Alessandro Pulsoni, Maurizio Martelli, Maria Teresa Voso, Massimo Breccia	2
8	The Role of Erythrocyte Sedimentation Rate (ESR) in Myeloproliferative and Lymphoproliferative Diseases: Comparison between DIESSE CUBE 30 TOUCH and Alifax Test 1 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Eleonora Nicolai, (unknown), (unknown), (unknown), Renato Massoud, (unknown), Adriano Venditti, Massimo Pieri, Sergio Bernardini	4
9	Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 2023 ·Blood Advances ·(unknown), (unknown), (unknown), Alfonso Piciocchi, (unknown), Tiziana Ottone, Emiliano Fabiani, Mariadomenica Divona, Serena Travaglini, Maria Rosaria Pascale, Hussein Awada, Arda Durmaz, Valeria Visconte, Matteo Giovanni Della Porta, Adriano Venditti, Jaroslaw P. Maciejewski, Carmelo Gurnari, Maria Teresa Voso	11
10	MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs’ patients 2023 ·Leukemia ·Gianfranco Catalano, (unknown), (unknown), Elvira Pelosi, Germana Castelli, Elisabetta De Marinis, (unknown), Serena Travaglini, Tiziana Ottone, Mariadomenica Divona, Maria Ilaria Del Principe, Francesco Buccisano, Luca Maurillo, Emanuele Ammatuna, Ugo Testa, Clara Nervi, Adriano Venditti, Maria Teresa Voso, Nélida I. Noguera	14
11	Measurable residual disease monitoring in patients with acute myeloid leukemia treated with lower‐intensity therapy: Roadmap from an ELN‐DAVID expert panel 2023 ·American Journal of Hematology ·Farhad Ravandi, Jacqueline Cloos, Francesco Buccisano, Richard Dillon, Konstanze Döhner, Sylvie Freeman, Christopher S. Hourigan, G. J. Ossenkoppele, Gail J. Roboz, Marion Subklewe, Christian Thiede, (unknown), Peter J.M. Valk, Adriano Venditti, Andrew H. Wei, Roland B. Walter, Michael Heuser	10
12	Impact of HLA Class I Antigen, Killer Inhibitory Receptor, andFCGR3A Genotypes on Breast Cancer Susceptibility and TumorStage 2023 ·Current Molecular Medicine ·A. Canossi, Anna Aureli, Tiziana Del Beato, Giorgio Novelli, Oreste Claudio Buonomo, P Rossi, Adriano Venditti, F. Papola, Giuseppe Sconocchia	2
13	Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies 2019 ·Quality of Life Research ·Kathrin Sommer, Francesco Cottone, Neil K. Aaronson, Peter Fayers, Paola Fazi, Gianantonio Rosti, Emanuele Angelucci, Gianluca Gaïdano, Adriano Venditti, Maria Teresa Voso, Michele Baccarani, Marco Vignetti, Fabio Efficace	16
14	A Leukemia-Associated CD34/CD123/CD25/CD99+ Immunophenotype Identifies FLT3 -Mutated Clones in Acute Myeloid Leukemia 2015 ·Clinical Cancer Research ·Daniela F. Angelini, Tiziana Ottone, Gisella Guerrera, Serena Lavorgna, (unknown), Francesco Buccisano, Marco De Bardi, Francesca Gargano, Luca Maurillo, Mariadomenica Divona, Nélida I. Noguera, Maria Irno Consalvo, Giovanna Borsellino, Giorgio Bernardi, Sergio Amadori, Adriano Venditti, Luca Battistini, Francesco Lo‐Coco	57
15	CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY 2014 ·Mediterranean Journal of Hematology and Infectious Diseases ·Maria Ilaria Del Principe, Luca Maurillo, Francesco Buccisano, Giuseppe Sconocchia, Mariagiovanna Cefalo, (unknown), Ambra Di Veroli, (unknown), (unknown), Massimiliano Postorino, (unknown), (unknown), Giovanni Del Poeta, Sergio Amadori, Adriano Venditti	38
16	The revised IPSS predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WPSS: validation by the GROM Italian regional database 2013 ·Journal of Clinical Oncology ·Maria Teresa Voso, S. Fenu, Roberto Latagliata, Francesco Buccisano, Alfonso Piciocchi, (unknown), Massimo Breccia, Marianna Criscuolo, (unknown), S Mancini, Pasquale Niscola, (unknown), (unknown), (unknown), Marco Maria D’Andrea, (unknown), Giuseppe Leone, Adriano Venditti	1
17	Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia 2011 ·Blood ·Francesco Buccisano, Luca Maurillo, Maria Ilaria Del Principe, Giovanni Del Poeta, Giuseppe Sconocchia, Francesco Lo‐Coco, William Arcese, Sergio Amadori, Adriano Venditti	185
18	Sequential Valproic Acid/All- trans Retinoic Acid Treatment Reprograms Differentiation in Refractory and High-Risk Acute Myeloid Leukemia 2006 ·Cancer Research ·Giuseppe Cimino, Francesco Lo‐Coco, Susanna Fenu, Lorena Travaglini, Erica Finolezzi, Marco Mancini, Mauro Nanni, (unknown), Francesco Fazi, Fabrizio Padula, Roberto Fiorini, Maria Antonietta Aloe Spiriti, Maria Concetta Petti, Adriano Venditti, Sergio Amadori, Franco Mandelli, Pier Giuseppe Pelicci, Clara Nervi	102
19	Clinical Relevance of Minimal Residual Disease Detection in Adult Acute Myeloid Leukemia 2002 ·Journal of Hematotherapy & Stem Cell Research ·Adriano Venditti, Anna Tamburini, Francesco Buccisano, Giovanni Del Poeta, Luca Maurillo, Paola Panetta, (unknown), Maria Christina Cox, Sergio Amadori	19
20	AML-M0: a biological and clinical profile 1998 ·Cineca Institutional Research Information System (Tor Vergata University) ·Roberto Stasi, Giovanni Del Poeta, Adriano Venditti, Maria Christina Cox, Elisabetta Abruzzese, (unknown), Francesco Buccisano, Anna Tamburini, Aldo Pagano, Sergio Amadori	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact